TLR4, as a receptor of resistin, which has high expression in human breast cancer, also mediates the promoting effect of resistin on epithelial-to-mesenchymal transition and stemness in breast cancer, combined with the downstream NF-κB/STAT3 pathway37. The gene discussed is STAT3; the disease is breast carcinoma.